Neuropsychological evaluation and rehabilitation in multiple sclerosis – qualitative case study

Neuropsychological Evaluation and Rehabilitation in Multiple Sclerosis (NEuRoMS): refining the screening and management pathway in routine clinical practice (Phase 1: Work Package 2ii Qualitative Study)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15615992

Enrollment

Registered

2021-02-23

Start date

2021-05-01

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis Nervous System Diseases Multiple sclerosis

Interventions

The newly designed manualised NEuRoMS intervention is multi-faceted, involving various components (i.e., information provision, goal setting), and a range of strategies and techniques (e.g., psychoedu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. People with MS: 1.1. Diagnosis of MS 2.2. Received neuropsychological screening and mild cognitive problems identified (in WP2i IRAS ID: 276570) 2. Related informants: 2.1. Relative or carer supporting a person with MS 3. Clinicians: 3.1. Health professionals (e.g., neurologists, MS nurse specialists, psychologists, occupational therapists) delivering the NEuRoMS screening and management pathway to people with MS 4. Intervention providers: 4.1. Research nurses/assistant psychologists delivering the intervention to people with MS identified above in 1 All individuals: Aged 18 years or above, able and willing to give informed consent and able to communicate in English

Exclusion criteria

Exclusion criteria: 1. Do not have the mental capacity to consent to take part in the study 2. Are unable to communicate in English (standardised materials are to be used which have not yet been developed for other groups)

Design outcomes

Primary

Measure	Time frame
1. Improved understanding of how the NEuRoMS screening and management pathway is integrated within routine clinical practice (e.g. contextual factors which influence its delivery, those mechanisms which influence its affect and those outcomes which are described by interviewees) through qualitative data; measured throughout data collection by reviewing notes from monthly teleconferences/videoconferences with clinicians and supervision sessions with intervention providers, and at interviews with patients and related informants (within approximately 2 weeks of completing the intervention), and at interviews with clinicians and intervention providers (after experiencing different elements of the pathway; 3-8 months post patient recruitment). 2. Improved understanding of how the NEuRoMS intervention programme is experienced by those who deliver and receive it (e.g. behavioural elements of the intervention, essential resources needed for, and barriers to screening and intervention delivery) through qualitative data; measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers, intervention audio-recordings, and at interviews with patients and related informants (within approximately 2 weeks of completing the intervention) and intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment).	—

Measure

Time frame

1. Improved understanding of how the NEuRoMS screening and management pathway is integrated within routine clinical practice (e.g. contextual factors which influence its delivery, those mechanisms which influence its affect and those outcomes which are described by interviewees) through qualitative data; measured throughout data collection by reviewing notes from monthly teleconferences/videoconferences with clinicians and supervision sessions with intervention providers, and at interviews with patients and related informants (within approximately 2 weeks of completing the intervention), and at interviews with clinicians and intervention providers (after experiencing different elements of the pathway; 3-8 months post patient recruitment). 2. Improved understanding of how the NEuRoMS intervention programme is experienced by those who deliver and receive it (e.g. behavioural elements of the intervention, essential resources needed for, and barriers to screening and intervention delivery) through qualitative data; measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers, intervention audio-recordings, and at interviews with patients and related informants (within approximately 2 weeks of completing the intervention) and intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment).

—

Secondary

Measure	Time frame
1. Patient, related informant and intervention provider views of the intervention resource book, measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers, intervention audio-recordings, and at interviews with patients and related informants (within approximately two weeks of completing the intervention) and intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment) 2. Intervention provider views and experiences of the staff training package, measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers and at interviews with intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment) 3. Appropriateness of fidelity tools measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers and at interviews with intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment)	—

Measure

Time frame

1. Patient, related informant and intervention provider views of the intervention resource book, measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers, intervention audio-recordings, and at interviews with patients and related informants (within approximately two weeks of completing the intervention) and intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment) 2. Intervention provider views and experiences of the staff training package, measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers and at interviews with intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment) 3. Appropriateness of fidelity tools measured throughout data collection by reviewing notes from monthly supervision sessions with intervention providers and at interviews with intervention providers (after experiencing different elements of the intervention; 3-8 months post patient recruitment)

—

Countries

England, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026